Updates On Some Mining and Pharma Stocks: MTFB, HVO, PDL & GEMD

  • Dec 27, 2019 GMT
  • Team Kalkine
Updates On Some Mining and Pharma Stocks: MTFB, HVO, PDL & GEMD

Motif Bio Plc

Motif Bio Plc (LON: MTFB) is a biopharmaceutical company which concentrates on creating innovative antibiotics against dangerous and life-endangering infections. The company focuses on the development of its product, Iclaprim, which is a trained Gram-positive antibiotic with activity against methicillin-resistant Staphylococcus aureus (MRSA). Iclaprim works uniquely than other medicines and rapidly destroys bacteria in vitro. The medicine if approved, will have huge cost avoidance impact.

MTFB - News Updates

On 10th December 2019, the company announced about its voluntary de-listing for the company's American Depository Shares (ADS's) from the NASDAQ Capital Market.

On 29th November 2019, the company announced about the issued share capital of the company which contains 485.3 million shares of 0.01 pence each with voting rights.

On 18th November 2019, the company announced that Craig Albanese, Zaki Hosny, Charlotta Ginman, Mary Lake Polan and Andrew Powell offered their resignation and stepped down from the board on 15th November 2019, in order to reduce the company's expenses and to protect capital.

MTFB - Share Price Performance

While writing the report on 27th December 2019, at 09:09 AM GMT, MTFB share price was trading at GBX 0.401 per share on the LSE, down by 1.01 per cent or GBX 0.004 per share, as compared to the GBX 0.397 per share which was previous day closing price.

The company’s 52-week highest share price was GBX 44.90 per share which was reported on 06th February 2019, whereas the company’s 52-week lowest share price was 0.306 per share which was reported on 16th December 2019. Today’s share price was down by 99.10 per cent from 52-week highest price whereas the same share price was up by 31.05 per cent from the 52-week lowest price.

The market capitalisation of the company was GBP 1.92 million at the time writing. The share outstanding of the MTFB was reported at 485.35 million, and the free float was reported at 406.80 million.

The beta of the MTFB share was -0.4823 at the time of writing, which is inversely correlated to the benchmark market index’s movement.

 

Hvivo Plc

Hvivo Plc (LON: HVO) is a holding company whose previous name was Retroscreen Virology Group plc. The company was established in 1989 after it was spun out from Queen Mary University. The company in the medical enhancement services business is an industry-leader, the service which helps in human disease models based upon viral challenges. The company’s clinical examination program can speed up drug and vaccine development in breathing and contagious disease.

HVO – News Updates

On 27th December 2019, the company confirmed that it issued 83.4 million ordinary shares of 5 pence each with voting rights. The company held “zero” ordinary shares in treasury.

On 19th December 2019, the company announced the exercise of employee share options by an ex-employee in which application had been received to Alternative Investment Market for the entry of 2,500 new ordinary shares of 5 pence each.

On 13th December 2019, the company announced the exercise of employee share options by an ex-employee in which application had been received to Alternative Investment Market for the entry of 126,250 new ordinary shares of 5 pence each.

HVO - Share Price Performance

While writing the report on 27th December 2019, at 08:59 AM GMT, HVO share price was trading at GBX 12.0 per share on the LSE, unchanged from the previous close.

The company’s 52-week highest share price was GBX 41.40 per share which was reported on 10th January 2019, whereas the company’s 52-week lowest share price was 9.75 per share which was reported on 03rd December 2019. Today’s share price was down by 71.0 per cent from the 52-week highest price, whereas it was up by 23.1 per cent from the 52-week lowest price.

The market capitalisation of the company was GBP 10.01 million at the time writing. The share outstanding of the HVO was reported at 83.42 million, and the free float was reported at 60.59 million.

The beta of the HVO share was -0.39 at the time of writing, which is inversely correlated to the benchmark market index’s movement.

Petra Diamonds

Petra Diamonds Ltd (LON: PDL) is a diamond mining company which regularly delivers gem and quality diamonds to the global market. The company’s purpose is to discover the world’s great product efficiently, and this purpose has led the company to contribute to the industry and provide long-standing value to its stakeholders. The company has interests in four generating operations: three in South Africa (Finsch, Cullinan and Koffiefontein) which are underground mines and the fourth one is in Tanzania (Williamson) which is an open-pit mine. The company also holds an exploration programme in Botswana (South Africa).

PDL – News Updates

On 17th December 2019, the company reported the selection of Peter Hill CBE as Chairman and Non-Executive Director from 1st January 2020. In succession to founder Adonis Pouroulis, Peter will be the Non-Executive Chairman as well from 31st March 2020.

On 12th December 2019, the company announced that Eskom had instructed that its load curtailment restrictions had been lifted. The company's mining operations operate at normal load levels in South Africa now.

PDL - Share Price Performance

While writing the report on 27th December 2019, at 10:19 AM GMT, PDL share price was trading at GBX 8.50 per share on the LSE, a rise of 1.80 per cent or GBX 0.150 per share, as compared to the GBX 8.35 per share which was the previous day closing price.

The company’s 52-week highest share price was GBX 46.42 per share which was reported on 14th January 2019, whereas the company’s 52-week lowest share price was 6.18 per share which was reported on 03rd October 2019. Today’s share price was down by 81.68 per cent from 52-week highest price whereas the same share price was up by 37.54 per cent from the 52-week lowest price.

The market capitalisation of the company was GBP 72.0 million at the time writing. The share outstanding of the PDL was reported at 865.43 million, and the free float was reported at 812.26 million.

The beta of the PDL share was 0.43 at the time of writing, which means it is less volatile as compared to the benchmark market index’s movement.

 

Gem Diamonds Ltd.

Gem Diamonds Ltd. (LON: GEMD) is a prominent producer of High-Value Diamonds. The company works in the Ghaghoo mine in Botswana and Letšeng Diamond mine in Lesotho with Manufacturing & Sales Marketing abilities in Belgium and Head Office in the United Kingdom. After the company’s acquisition of Letšeng in 2006, it has produced more than 60 large and 100 plus carat and top colour exceptional white diamonds.

GEMD – News Updates

On 29th November 2019, the company announced the proportion of votes cast opposed to Resolution 8 to re-elect Clifford Elphick and Resolutions 5 to re-elect Harry Kenyon-Slaney. However, Resolution 8 passed with 78.72% as well as Resolution 5 passed with 76.60% contributing shareholders voting in favour.

GEMD - Trading Updates

On 5th November 2019, for the period from 1st July 2019 to 30th September 2019, the company released the trading update.

The group recorded US$ 21.9 million cash out of which US$ 17.6 million is attributable to Gem Diamonds Ltd. The company’s net debt was reported at US$ 11.6 million at the period end. The controlled corporate costs incurred reduced by US$ 1.0 million for the full year as compared to US$ 9.3 million in 2018.

The existing and un-drawn facilities were US$ 49.3 million at the period end as compared to US$ 61.5 million for the second quarter of 2019.

GEMD - Share Price Performance

While writing the report on 27th December 2019, at 10:30 AM GMT, GEMD share price was trading at GBX 51.60 per share on the LSE, down by 0.19 per cent or GBX 0.10 per share, as compared to the GBX 51.50 per share, which was previous day closing price.

The company’s 52-week highest share price was GBX 114.0 per share which was reported on 28th December 2019, whereas the company’s 52-week lowest share price was 48.19 per share which was reported on 03rd December 2019. Today’s share price was down by 79.59 per cent from the 52-week highest price, whereas it was up by 7.07 per cent from the 52-week lowest price.

The market capitalisation of the company was GBP 71.31 million at the time of writing. The share outstanding of the GEMD was reported at 138.98 million, and the free float was reported at 108.33 million.

The beta of the GEMD share was -0.22 at the time of writing, which means it is inversely correlated to the benchmark market index’s movement.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK